Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.065 USD | -1.39% | -1.83% | -1.83% |
05-09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.83% | 204M | |
+41.11% | 50.93B | |
-0.39% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.13% | 26.02B | |
-22.01% | 18.9B | |
+8.11% | 13.21B | |
+24.20% | 12.17B | |
+30.62% | 12.16B |
- Stock Market
- Equities
- LCTX Stock
- News Lineage Cell Therapeutics, Inc.
- Lineage Cell Therapeutics : Noble Capital Initiates Coverage on Lineage Cell Therapeutics With Outperform Rating, $8 Price Target